Since we already showed that the sex-dimorphic up-regulation of egr expression in hemocytes is a source of tumor size sex difference, and upd2 expression is potentially driven by JNK signaling, we examined the expression of upd2 in tumors with sex-modified hemocytes. Here, MAPK8 is linked to neoplasm.